Clinical trial
A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
NCT06672575 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- January 30, 2025
- Completion date
- January 31, 2030
- Enrollment
- 45 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.